DOCSLIB.ORG

First Name Last Name

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
First Name Last Name JEREMY BAROFSKY (updated May 2015) ________________________________________________________________________________ Contact Information: Brookings Institution [email protected] Okun-Model Fellow Office: 213-821-6486 1775 Massachusetts Ave, Suite 817 Mobile: 617-780-9634 Washington DC, 20005 www.jeremybarofsky.com Current: Brookings Institution Okun-Model Fellow, 2014 - Present Previous: University of Southern California Schaeffer Center for Health Policy and Economics Postdoctoral Research Scholar, 2012 – 2014 Education: Harvard University Department of Global Health and Population, School of Public Health Doctor of Science (Economics Concentration) 2007 – 2012 Thesis: Evaluating the Impact of Health Insurance in Developing Nations using Mexico’s Seguro Popular. Thesis advisors: David Canning, David Cutler, Amitabh Chandra, David Laibson Boston University M.A., Economics, Department of Economics, 2004 – 2005 B.A., Economics and Public Policy, Magna Cum Laude, 1999 –2003 Research Interests: Health Economics, Development Economics, Behavioral Economics, Public Economics. Publications and Submissions: Universal Health Coverage for the Poor: A Cost-Benefit Analysis of Mexico's Seguro Popular. Submitted. Malaria Eradication and Economic Outcomes in Sub-Saharan Africa: Evidence from Uganda (with Claire Chase and Tobenna Anekwe). Revise and Resubmit Journal of Health Economics Substitutes in Medical Care? The impact of Medicare Part D on Spending and Utilization (with Geoffrey Joyce, Julie Zissimopoulos, Patty St. Claire, Yuhui Zheng). Submitted The Effect of PEPFAR on Employment in sub-Saharan Africa (with Neeraj Sood, Zach Wagner). Forthcoming Health Affairs 2015. Assessing the effect of the 2001-2006 Mexican health reform: an interim report card, Gakidou, E., et al. Lancet, 2006; Vol. 368, Issue 9550, pp. 1920-1935. Evidence is good for your health system: policy reform to remedy catastrophic an impoverishing health spending in Mexico, Knaul, F, et al. Lancet, 2006; Vol. 368, Issue 9549, 1828-1841. Estimating population cause-specific mortality fractions from in-hospital mortality: validation of a new method. Murray, CJL., et al. PLoS Medicine, November 2007, Vol. 4, Issue 11. Working Papers: An Impact Evaluation of Medication Availability and Use in Mexico (with Diane Kuhn and Gary King). HIV Treatment and Economic Outcomes in Malawi (with Neeraj Sood, Zach Wagner). Seriously, I'll do it tomorrow: Procrastination in Health Insurance Enrollment using Mexico's Seguro Popular. Work in Progress: Financial Consequences of States Not Expanding Medicaid (with Silvia Barcellos) Behavioral Determinants of Medicaid Enrollment after the ACA Expansion (with Silvia Barcellos) Understanding the effect of HIV treatment on health and economic outcomes in sub-Saharan Africa: Evidence from clinic data in Malawi (with Victoria Baranov) Grants, Awards, and Fellowships: 2014 University of Southern California Population Research Center Grant ($10,000) 2010-2012 Lab for Economics Applications and Policy Research Grant ($12,000) 2010-2011 Weatherhead Center for International Affairs at Harvard University ($5,000) 2010-2011 Institute for Quantitative Social Science Research Grant ($5,000) 2010-2011 Harvard Glickenhaus Fellowship ($1,500) 2007-2012 Harvard University School of Public Health Doctoral Fellowship (tuition and stipend) 2008 IPUMS-International Research Award, Best Graduate Student Paper Invited Presentations: 2015 USC-Brookings Conference on Health and Wellbeing, Brookings Institution Economics Studies Seminar, Pacific Conference for Development Economics UCSD, Academy Health Conference (planned), International Health Economics Associations (planned). 2014 Population Association of America Conference, USDA Economic Research Service, Academy Health Conference, American Society of Health Economists Conference. 2013 Harvard University Healthcare Policy Department; University of Southern California Schaeffer Center for Health Policy and Economics; International Health Economics Association, Eighth Congress, Sydney Australia; RAND Corporation DELI Seminar. 2012 Harvard University Labor Economics Seminar. 2011 Harvard University Development Economics Seminar; International Health Economics Association, Seventh Congress, Toronto, Canada. Teaching Experience: Fall 2011 Harvard University, Cambridge MA, Economics Department, Teaching Fellow, Intermediate Microeconomic Theory. Spring 2010 Harvard University, Cambridge MA, Economics Department, Teaching Fellow, and 2011 The Economics of Discontinuous Change. Fall 2009 Harvard University, Cambridge MA, Teaching Fellow, The Business and Politics of Health. Research Experience and Other Employment: 2010 – 2012 Federal Reserve Bank of Boston, Center for Behavioral Economics and Decision- making, Research Assistant for Julian Jamison. 2010 – 2011 Program in Health Care Financing, Research Assistant for Professor William Hsiao. 2005-2007 Fellow, Harvard Initiative for Global Health, Research Assistant for Professor Christopher Murray. 2007 / 2010 Field Experience in Mexico (2010) and Tanzania (2007). Languages: English: native, Spanish: fluent, Swahili: basic greetings Professional Activities: Referee for Journal of Health Economics, Journal of Development Economics, Health Affairs, JAMA Pediatrics External reviewer for the International Initiative for Impact Evaluation References: Dana Goldman, PhD David Cutler, PhD Norman Topping Chair, Medicine and Public Policy Professor of Applied Economics Director, Schaeffer Center for Health Policy and Harvard University, Department of Economics Economics, University of Southern California, Littauer, 1875 Cambridge St, Cambridge, MA 02138 University Gateway 100C, Los Angeles, CA 90089 617-496-5216, [email protected] 213-821-7948, [email protected] David Canning, PhD Amitabh Chandra, PhD Professor of Economics and International Health Professor of Public Policy Harvard University, School of Public Health Harvard University, Kennedy School of Government 665 Huntington Avenue, Boston, MA 02115 Mailbox 26, 79 JFK Street, Cambridge, MA 02138 617-432-6336, [email protected] 617-496-7356, [email protected] .
Load more

Recommended publications
  • The Hippocratic Dilemmas Guanxi and Professional Work in Hospital Care in China
    China Perspectives 2016/4 | 2016 The Health System and Access to Healthcare in China The Hippocratic Dilemmas Guanxi and Professional Work in Hospital Care in China Longwen Fu and Cheris Shun-Ching Chan Electronic version URL: http://journals.openedition.org/chinaperspectives/7091 ISSN: 1996-4617 Publisher Centre d'étude français sur la Chine contemporaine Printed version Date of publication: 1 December 2016 Number of pages: 19-27 ISSN: 2070-3449 Electronic reference Longwen Fu and Cheris Shun-Ching Chan, « The Hippocratic Dilemmas », China Perspectives [Online], 2016/4 | 2016, Online since 01 December 2017, connection on 28 October 2019. URL : http:// journals.openedition.org/chinaperspectives/7091 © All rights reserved Special feature China perspectives The Hippocratic Dilemmas Guanxi and Professional Work in Hospital Care in China LONGWEN FU AND CHERIS SHUN-CHING CHAN ABSTRACT: Patients mobilising guanxi (interpersonal relations) to gain access to hospital care is prevalent in post-Mao China. Yet few studies have centred on how medical professionals deal with guanxi patients. Based on ethnographic research and applying an analytical frame of Chi - nese guanxi developed by Fei Xiaotong (1992 [1948]) and Cheris Shun-ching Chan (2009), this article examines the dilemmas that Chinese phy - sicians face in weighing professional standards versus guanxi . We divide the patients into three general categories: patients without any guanxi , patients with weak to moderate ties with physicians, and patients with strong ties with physicians. We find that physicians face few di - lemmas when they interact with patients without guanxi . They largely adhere to their professional code of practice and generally display do - minance over the patients.
    [Show full text]
  • View Latest Version Here. the Challenge Of
    This transcript was exported on Jul 02, 2020 - view latest version here. Steven Goldstein: Good morning, good afternoon, good evening, wherever you are. My name is Steven Goldstein and I'm the director of the Taiwan Workshop at the Fairbank Center at Harvard University. And I'm very pleased today to moderate a round table on the COVID-19 virus and the experience in Taiwan. Let me just start off with a few thoughts. Taiwan appears to be the land of miracles. In the 1970s, when I was a grad... well, I was more than a graduate student, the Taiwan miracle was the economic transformation that took place in Taiwan, after the establishment of rule on the Island. In the two thousands, or in the turn of the 20th century, the Taiwan miracle was a political miracle. It was the democratization of an authoritarian regime. Steven Goldstein: And now people are talking of a third miracle Taiwan's response to the COVID-19 virus. You see the more I read about it, the more I see terms like gold standard being used to characterize the Taiwan experience. Miracle's not a good word, because every one of those miracles, including the miracle today has been the result of political leadership and societal participation. They're the result of policies led by political leaders with the participation and cooperation of the people. This was unquestionably the case in the first two miracles. And today it's becoming increasingly clear that the same holds for the present miracle. Political leadership, societal effort, combined with technological capabilities, social policies, government institutions have all played central roles in Taiwan's response.
    [Show full text]
  • Dr. William Hsiao
    Distinguished Achievement Citation William Hsiao Class of 1959 With this presentation of Ohio Wesleyan’s Distinguished Achievement Citation, the Ohio Wesleyan University Alumni Association Board of Directors is honored and privileged to recognize William Hsiao and his career as a public administrator, humanitarian, and professor. He is considered one of the world's foremost experts on health care economics and financing. His advice to leaders of state and government both here and abroad has changed the lives of millions of people across the world. A native of Beijing, Dr. Hsiao graduated from OWU in 1959 with a degree in Physics and Math. Following graduation, he worked as an actuary for the Connecticut General Life Insurance Company. In 1968, Dr. Hsiao became Deputy Chief Actuary for the Social Security Administration where he led two blue-ribbon panels regarding the actuarial viability of the Social Security System. He left government service in 1971 and entered the graduate program at Harvard University where he obtained a Master of Public Administration, Master of Arts, and Ph.D. in Economics in 1982. During his studies, he served as a consultant to the U.S. House and Senate on Social Security. Dr. Hsiao was appointed to the faculty of the Harvard School of Public Health as an Assistant Professor in 1979 and became a full professor in 1986. He currently serves as the K.T. Li Professor of Economics at the Harvard School of Public Health. Dr. Hsiao regularly advises U.S. government agencies, foreign governments, and non-governmental organizations such as the World Bank, UNICEF, and the World Health Organization.
    [Show full text]
  • Gabriel M. Leung and John Bacon Shone
    (GLWHGE\ *DEULHO0/HXQJ DQG -RKQ%DFRQ6KRQH A Project of the Medical and Health Research Network The University of Hong Kong Hong Kong University Press The University of Hong Kong Pokfulam Road Hong Kong www.hkupress.org © 2006 Hong Kong University Press ISBN 978-962-209-804-6 (Hardback) ISBN 978-988-8139-55-2 (Paperback) All rights reserved. No portion of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage or retrieval system, without prior permission in writing from the publisher. British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library. 10 9 8 7 6 5 4 Printed and bound by CTPS Digiprints Ltd. in Hong Kong, China Contents Foreword ix Preface xi List of Contributors xv PART I Forces of Change 1 Part I Commentary History, Ethics and Forces of Change 3 John Bacon-Shone and Gabriel M. Leung 1. A Historical Review: The Colonial Legacy 17 Derek Gould 2. Philosophy, Ethics and Societal Values in Health System Reform 27 Marc Roberts 3. Confucian Care-Based Philosophical Foundation of Health Care 41 Julia Tao 4. Implications of the Demographic Transition 61 Paul Yip, Joseph Lee and C.K. Law 5. Changing Patient Expectations 81 Iris Chan and Mary Ann Benitez 6. Comparative Health System Models in East Asia 95 Ruiping Fan and Ian Holliday vi Contents 7. The Role of Public Health in Social Justice: The Next Steps in 109 Hong Kong Anthony Hedley PART II The Organisation and 135 Management of Health Care Parts II & III Commentary Organisational, Management and Quality of Care Issues 137 Gabriel M.
    [Show full text]
  • APBC 2013 Final Program
    Conference Program Image by Magnus Larsson under Creative Commons APBC 2013 | 1 Contents Welcome ....................................................................... 2 APBC 2013 Organization ............................................... 3 General Information ...................................................... 5 Keynote Speakers ..........................................................12 Conference Schedule .................................................. 14 Posters Index ................................................................. 21 Sponsors ........................................................................ 26 Notes ............................................................................. 28 2 | APBC 2013 APBC 2013 | 3 Welcome APBC 2013 Organization Dear APBC 2013 attendee, Conference Chair • Steven Jones, BC Genome Sciences Centre, Canada On behalf of the APBC 2013 organizing committee, it is a pleasure to welcome you in Vancouver, British Columbia. This is the 11th Asia-Pacific Bioinformatics Conference, and the first to extend to the Pacific coast of North America. Program Chair • S. Cenk Sahinalp, Simon Fraser University, Canada This year we will have 40 papers presented in APBC selected out of more than 100 submissions. We will also feature 3 distinguished plenary speakers Local Organizing Committee who will each provide salient insights into the application of next-generation • Inanc Birol, University of British Columbia, Canada DNA sequencing. Additionally, an industry panel on application of bioinformatics
    [Show full text]
  • Challenges for the Health Systems of China and India
    June 2008 O Volume 2 O Issue 3 PARDEE RAND GRADUATE SCHOOL Policy Insight Caring for a Third of the World’s Population Challenges for the Health Systems of China and India hina and India together have more than 2 ularly in improving birth outcomes and preventing Cbillion residents, accounting for nearly 40 communicable diseases. percent of the total world population. Over Overall, people in China live longer, healthier the past 50 years, both of these countries have made lives than people in India. The difference between substantial gains in health, including increases in women is larger than that for men, resulting in life expectancy, reductions in infant mortality, and part from the 10-fold greater maternal death rate Sai Ma, Ph.D. PRGS Alumna the eradication of several diseases. Yet China and for Indian compared with Chinese women.1 Assistant Scientist, Johns Hopkins University India still lag behind many countries on key mea- Significant differences exist in causes of death sures of health, and the health gains achieved have as well. In China, noncommunicable diseases, been uneven across subpopulations. particularly chronic obstructive pulmonary dis- Comparing the health systems in China and ease and cancer, account for 77 percent of all India illuminates the health challenges common to deaths. In India, however, more than 40 percent both nations as well as those that are distinct to of all deaths are due to communicable diseases— each of them. Such a comparison is also timely, as including HIV/AIDS, diarrhoeal diseases, respira- health care reform is high on the political agenda tory infections, and perinatal conditions (Liu, Rao, Neeraj Sood, Ph.D.
    [Show full text]
  • Act 128 Health System Reform Design
    Act 128 Health System Reform Design Achieving Affordable Universal Health Care in Vermont Submitted by WILLIAM C. HSIAO, PhD, FSA K.T. Li Professor of Economics Harvard University STEVEN KAPPEL, MPA Principal Policy Integrity, LLC JONATHAN GRUBER, PhD Professor of Economics Massachusetts Institute of Technology And a team of health policy analysts February 17, 2011 ACKNOWLEDGEMENTS We would like to thank the more than 100 individuals who met or talked with us over the course of this study, sharing their views, ideas and insights on health reform in Vermont. Without their contributions, our work would not have been possible. _________ We would also like to thank the numerous Vermonters and Vermont organizations who provided thoughtful comments and insight during the public comment period. Their efforts helped make this report better, clearer and hopefully more useful to the State of Vermont. The comments pointed out some gaps, lack of clarity and inadequate analysis in our draft report. We are deeply grateful for these comments and have revised our draft report to improve the completeness and clarity of our analysis. The comments painted a clear picture of the diversity of views, of experiences with the health care system, of the deep feelings and beliefs about what a health care system should be, and the desire to do better for Vermonters. The comments also showed a sense of trepidation at the prospect of major systemic change, despite a general agreement over the unacceptability of the status quo. Health care touches us all, in personal, professional and economic ways. Major change brings uncertainties. We strongly believe, however, that Vermont can achieve its goals and set a model for the nation for an equitable, affordable, high-performing health system.
    [Show full text]
  • Via E-Mail to [email protected]
    Via e-mail to [email protected] February 3, 2011 William Hsiao, Ph.D. 124 Mt. Auburn Street, Suite 410 South Cambridge, MA 02138 Dear Dr. Hsiao: On behalf of Fletcher Allen Health Care, Vermont’s academic medical center, I would like to thank you and your team for the efforts you put into developing the draft Act 128 report issued on January 19. Despite the limitations placed on that work that you have described – a small budget and short timeframe – the draft report reflects a great deal of research, analysis and thoughtfulness. We also appreciate the many meetings you and your team hosted for so many stakeholders, including Fletcher Allen’s clinical and administrative leaders. We were pleased to see that many of the concepts that are common to the three major designs included in the report are ones that have been under discussion, or have been implemented in some form in Vermont, in the past several years. We at Fletcher Allen have been fully supportive of those reforms, and have already incorporated many of them into our operations and organizational culture. Those include: An integrated care system that includes ten primary care practices, a large multi- specialty physician practice (the University of Vermont Medical Group, physicians jointly employed by Fletcher Allen and the UVM College of Medicine), and a full spectrum of inpatient and outpatient care services. As recognized on pages 49 – 50 of the report, Fletcher Allen’s hospital service area is among the highest-performing in the three-state region discussed in the Tri- State Report commissioned by the Department of Banking, Insurance, Securities and Health Care Administration in 2010, including having the lowest per- member per-month costs; the lowest rates of Emergency Department visits, potentially-avoidable ED visits, and hospitalizations for ambulatory-sensitive conditions; and among the lowest hospital re-admission rates.
    [Show full text]
  • Global Hospital Management Survey – China
    Global Hospital Management Survey – China Management in Healthcare Report CONTENTS Contents .......................................................................................... 1 Executive Summary ......................................................................... 2 GHMS - China .................................................................................. 3 Public Hospital Reform in China ........................................................................... 3 Project Background............................................................................................... 5 Project Methodology ............................................................................................ 6 Pilot Study ....................................................................................... 8 Hospital Selection ................................................................................................. 8 Interview Selection ............................................................................................... 9 Summary Results ........................................................................... 10 Overall Hospital Management Score .................................................................. 10 International Comparisons ................................................................................. 11 Factors for Variation ........................................................................................... 13 Hospital Management in China .....................................................
    [Show full text]
  • Universal Health Coverage: the Case of China William Hsiao, Mingqiang Li and Shufang Zhang
    Working Paper 2014-15 Universal Health Coverage The Case of China William Hsiao, Mingqiang Li and Shufang Zhang prepared for the UNRISD project on Towards Universal Social Security in Emerging Economies: Process, Institutions and Actors November 2014 UNRISD Working Papers are posted online to stimulate discussion and critical comment. The United Nations Research Institute for Social Development (UNRISD) is an autonomous research institute within the UN system that undertakes multidisciplinary research and policy analysis on the social dimensions of contemporary development issues. Through our work we aim to ensure that social equity, inclusion and justice are central to development thinking, policy and practice. UNRISD, Palais des Nations 1211 Geneva 10, Switzerland Tel: +41 (0)22 9173020 Fax: +41 (0)22 9170650 [email protected] www.unrisd.org Copyright © United Nations Research Institute for Social Development This is not a formal UNRISD publication. The responsibility for opinions expressed in signed studies rests solely with their author(s), and availability on the UNRISD Web site (www.unrisd.org) does not constitute an endorsement by UNRISD of the opinions expressed in them. No publication or distribution of these papers is permitted without the prior authorization of the author(s), except for personal use. Contents Acronyms ......................................................................................................................... ii Summary .........................................................................................................................
    [Show full text]
  • An Informal Conversation with Professor William Hsiao | Globalhealt
    An Economist’s Perspective on the U.S. Health Care System: An Inform... http://globalhealth.harvard.edu/news/economist’s-perspective-us-health-c... GOING GLOBAL PREPARING LEADERS WORLDWIDE WORK LATEST ACTIVITIES ABOUT HGHI Home » Latest Activities Informal Conversations with ... An Economist’s Perspective on the U.S. Health The HGHI Informal Conversation Series offers Care System: An Informal Conversation with faculty and students the opportunity to engage in dialogue on cutting-edge cross-disciplinary Professor William Hsiao issues, exploring new ideas, challenges, and opportunities that impact global health. Below Does Lipitor — $6 per dose in is the schedule of speakers for Fall 2013. New Zealand — really need to All series conversations take place from cost $124 in the U.S.?[1] Why 12-1:30 PM at the Harvard Global Health are Americans charged up to Institute, 104 Mt. Auburn Street, 3rd floor, five times more than patients in Cambridge, Massachusetts other countries for a Wednesday, October 30, colonoscopy or hip 2013 replacement? Why do just 40 Ahmed Ragab, PhD, MD, percent of American medical graduates choose to practice primary care Richard T. Watson when the ratio is 60 percent in Europe? Can ethics balance profit to Assistant Professor of shape an American health care system that is equitable, affordable, and Science and Religion, effective? Harvard Divinity School. Professor Ragab will be discussing the role of religion and culture in global health. These were just some of the provocative questions that Professor William Hsiao invited students, faculty, and staff to explore on November 21, Thursday, November 21, 2013, as part of the Harvard Global Health Institute (HGHI) "Informal 2013 Conversations," a series of roundtable luncheons that invites dialogue on William Hsiao, PhD, K.
    [Show full text]
  • A Unique Health Care System for Vermont
    The Vermont Option: Achieving Affordable Universal Health Care Submitted by WILLIAM C. HSIAO, PhD, FSA K.T. Li Professor of Economics Harvard University STEVEN KAPPEL, MPA Principal Policy Integrity, LLC JONATHAN GRUBER, PhD Professor of Economics Massachusetts Institute of Technology and a team of health policy analysts June 21, 2010 TABLE OF CONTENTS Introduction ................................................................................................................................................... 2 Bidder Qualifications .................................................................................................................................... 3 I. Background .......................................................................................................................................... .. 4 I.1 Financing .......................................................................................................................................... 5 I.2 Payment ........................................................................................................................................... .. 8 I.3 Organization .................................................................................................................................... .. 9 I.4 Regulation ....................................................................................................................................... 1 0 II. Goals and Strategies ............................................................................................................................
    [Show full text]